King Charles' coronation cost £72 million, significantly less than Queen Elizabeth's funeral, but still facing criticism over excessive spending.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Adani and executives face expanded U.S. indictment for alleged $250 million bribery scheme, leading to significant financial and political repercussions in India.
King Charles' coronation cost £72 million, significantly less than Queen Elizabeth's funeral, but still facing criticism over excessive spending.
Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
Adani and executives face expanded U.S. indictment for alleged $250 million bribery scheme, leading to significant financial and political repercussions in India.